How is Janssen's record, in hiring the disabled for sales jobs?
Hiring the Disabled
mardi 30 septembre 2014
PFizer. Viagra commercial in the News
The porn star on at prime time during an mlb playoff game
Telling men to finish what they start
I guess after we finish screwing her. We can beat her right?
What a joke of a company to have a commercial like that.
Telling men to finish what they start
I guess after we finish screwing her. We can beat her right?
What a joke of a company to have a commercial like that.
PFizer. Viagra commercial in the News
Share your pathetic zoetis rep story.....
Today I followed my zoetis rep into an account that switched to me a few months ago. He must have been desperate because when the doctor invited me back after he left the doctor was laughing at how pathetic he was...... Said his manager was after him due to losing the business, mind you he is "key" accounts rep, he then went on to say that zoetis had the most advanced lepto on the market and put the most into R&D for lepto too.... All others were just saying they did. Cute! Lucky he wasn't waiting outside because I was gonna offer him a tissue! I wonder what phase of training zoetis teaches the sympathy sales call.... Get a life loser!
And as for zoetis having the most advanced lepto... If that's the case then why does your detailer reference the Moore study for safety when your vaccine wasn't even used in it?
And as for zoetis having the most advanced lepto... If that's the case then why does your detailer reference the Moore study for safety when your vaccine wasn't even used in it?
Share your pathetic zoetis rep story.....
Senior Management
Anthony Venditti. Are you kidding me!! Vindictive small man with a my way or the highway
mentality.
mentality.
Senior Management
Colorado mgr.
New Colorado manager has an ego bigger than mt. Kilimanjaro. Does nothing but belittle you while building himself up-- this guy is unbelieveable!
Colorado mgr.
Law regarding bonus when you leave?
Is it true that when you leave, you are due your bonus up to the last day of work?
Law regarding bonus when you leave?
Goodbye Emails
Has anyone noticed that these company-wide "I'm leaving" emails are becoming more and more frequent? Thanking the company (for what, who knows) and then letting them know they're moving on. I sure hope I'm able to join that list of people jumping ship soon. This company is getting worse and worse by the day and there are more and more idiots working in sales and at the corporate headquarters. There are a lot of changes coming and I don't want to be here to find out what they are.
Goodbye Emails
Chainsaw Suzie taken the wheel.............
The former ZS clone ready light it up.
Chainsaw Suzie taken the wheel.............
Town Hall Meeting
Don't we have a Town Hall conference call coming up?
Hmmm, wonder what the topics will be...
Hmmm, wonder what the topics will be...
Town Hall Meeting
Good Morning, Merck!
It's a new day, just like yesterday once was and tomorrow soon will be. On this new day, just as yesterday, I intend to find as many ways as humanly possible to transfer merck's resources to to myself and others (my favorite caterers) while doing absolutely nothing to promote the God-awful products that are in my bag. After all, I have my own products to sell!
Be well!
Be well!
Good Morning, Merck!
Will this be end of Patient First?
New Chairman, who is now considered as one of Witty's successors, will end this stupid PF?
He should prove his being named as a chairman,
He might feel tempted to deny the old way of working.
He should prove his being named as a chairman,
He might feel tempted to deny the old way of working.
Will this be end of Patient First?
lundi 29 septembre 2014
Position Info
Can someone please provide some general info on the quality of this company and the territory sales position?
The recruiter I've spoken with says 75-95k base with 75k at plan. Is this real? Is this company at all stable? Is the company growing significantly (like the recruiter is saying)?
I don't want to bother interviewing if this isn't going to be a good fit.
Thanks
The recruiter I've spoken with says 75-95k base with 75k at plan. Is this real? Is this company at all stable? Is the company growing significantly (like the recruiter is saying)?
I don't want to bother interviewing if this isn't going to be a good fit.
Thanks
Position Info
Annual Income for Sales Specialist
what is the annual income sales specialist are seeing? what kind of drug test hair or urine?
Annual Income for Sales Specialist
Fire the not needed sales rep
Fire your entire sales force and save millions- use rent a reps. Your reps are way overpaid for their ROI...considering scrips are now more dependent on contracts more than ever.
Add more Managed Care reps- its the wave of the future.
Add more Managed Care reps- its the wave of the future.
Fire the not needed sales rep
THE REAL QUESTION IS…
When are the Alpha reps going to start talking about Brintellix, let alone selling it??? I know they were told to concentrate on AM, but my God, they are getting bonus off our efforts solely!! It's time they started pulling their weight with Brintellix.
THE REAL QUESTION IS…
TIME TO MOVE ON!!!
Folks lets face it, if the two sides were close enough to an agreement and Allergan wasn't catching as much heat from their investors; we would by now know our fate as an organization. No matter how quite it has been at home office there is no doubt that someone or something would have triggered all us of at least a slight hint that a deal has been reached by now. Just was not to be and we should all stop wondering when and accepting the reality.
TIME TO MOVE ON!!!
Warning Stay Away
i have been with Biogen for 5 years and when I joined them I loved working here. Over the last year this company has decided to become huge pharma with a bunch of hires from top 10 pharma companies. This has led to analysis paralysis and weeks of meetings to get even small things accomplished. Our new office has no privacy and this is supposed to foster more communication. Of all the biotech companies in Cambridge this is def one to stay away from at all costs.
Warning Stay Away
Starts on Valentine's Day....
And we know the hens will all be there.........watching, waiting, anticipating. ;)
http://ift.tt/1tGDERy
http://ift.tt/1tGDERy
Starts on Valentine's Day....
General Med Webcast?
What's the deal with the webcast call next Tuesday? Realignment? Anyone know?
General Med Webcast?
Genzyme MS/ Infusion Support Mgr offers
Has anyone heard if they have given offers for the Infusion Support Manager positions yet?
Genzyme MS/ Infusion Support Mgr offers
VILEX COMPETITORS
Who currently are considered the direct competitors of Vilex Inc.?
Thanks for your help!
Thanks for your help!
VILEX COMPETITORS
Layoffs after VTP?
Some of my friends that are still working at Amgen want to know if there are any rumors on CAFE PHARMA about when the layoffs will begin after Amgen assesses who took VTP and what jobs or staff are deemed no longer necessary and will be offered a reduction in force package? I saw the post about the "sales" layoffs but I haven't seen any rumors regarding other staff.
Layoffs after VTP?
Assembly Line Hire......
Definitely like a factory style assembly line with hiring. Massive number of recruiters and managers who will hire only the buds and the less experienced. Big turn off! Can't imagine working in this chaos! Bet it's a revolving door! Yuk!
Assembly Line Hire......
dimanche 28 septembre 2014
Global Development NPH?
Anyone know what "NPH" stands for? I see this as part of "Global Development NPH." Does this indicate that the position is in India?
Global Development NPH?
? About novartis layoff plans
Hi, with alcon and wondering why novartis seems to give your divisions a " heads up" about layoffs but the rounds of Lay offs we have had, we have been given no notice or a 24 hr notice to sit by your phone. Why the difference? Has novartis always given a heads up or is the style they are using with alcon more typical? Just curious
? About novartis layoff plans
From a position of strength...listen up you minions
I just want to say that I don't give a sh*t about any of you unless you make me BILLIONS, not MILLIONS! I don't care about science except the science of making GREEN (CASH)! If your kids can't go to college or you can't pay for medical bills for a grievious disease, NOT MY PROBLEM! - Banker HBS Bob Bradway, Tony "Americans are stupid" Hooper, Sean "I'll do whatever you want if you keep my house big in Lake Sherwood" Harper
From a position of strength...listen up you minions
Ol 1000 or Orthofix Stimulator
I have been issued both an Orthofix Physiostim and a Don Joy OL1000
Bone stimulator via my workers comp. Very, very long story short, I have both devices and cannot seem to return either one. it seems like a no brainer to go for 30 minutes a day versus three hours. Do you have better results than the other? Thought I would go direct and ask the company reps what they thought. Thank you!!
Bone stimulator via my workers comp. Very, very long story short, I have both devices and cannot seem to return either one. it seems like a no brainer to go for 30 minutes a day versus three hours. Do you have better results than the other? Thought I would go direct and ask the company reps what they thought. Thank you!!
Ol 1000 or Orthofix Stimulator
Abbvie Might Walk Away From Shire Deal
From Bloomberg....
AbbVie Inc. (ABBV) is examining plans to raise additional financing to complete its takeover of Shire Plc (SHP), after U.S. officials imposed new obstacles to so-called tax inversion deals, people with knowledge of the matter said.
AbbVie may seek to borrow as much as $7 billion more than it originally anticipated because of new restrictions on using cash held offshore, two of the people said, asking not to be identified discussing a private matter. The deliberations are at an early stage, and are part of a comprehensive review of the Shire transaction’s structure after U.S. Treasury Secretary Jack Lew announced measures to make inversions more difficult this week, the people said.
President Barack Obama’s administration is looking at ways to halt a wave of acquisitions that allow U.S. companies to move their legal address overseas, potentially eroding the corporate tax base. The rules imposed this week, which Lew said are within the powers of the executive branch to enact without Congressional legislation, will make it more difficult for U.S. companies to finance inversion deals by using cash they hold overseas, beyond the reach of American taxes. While offshore money can still be used under the new regulations, it would be subject to a 35 percent tax rate.
No final decision on how to proceed has been made by AbbVie, which is still waiting for details on how the Treasury rules will be implemented and examining several scenarios, the people said. The company is working with advisers to gauge the cost of any increased borrowing, as well as its impact on credit ratings and the deal overall, one of the people added.
A spokeswoman for AbbVie said in an e-mail that rumors of AbbVie seeking additional financing are untrue. She declined to comment on whether the company would stand by the deal or walk away. A spokeswoman for Shire declined to comment.
AbbVie is still committed to completing the $55 billion merger, the people said. In addition to tax benefits, AbbVie would get Shire’s drugs for attention-deficit disorder and rare diseases, diversifying its own portfolio.
The measures announced by Lew on Sept. 22 impose curbs on loans or cash transfers from offshore subsidiaries to a new foreign parent -- which AbbVie would create by setting up a U.K.-domiciled company after buying Shire. The headline rate of tax on U.S. corporate earnings is 40 percent, compared with 21 percent in the U.K.
AbbVie, which is based in North Chicago, Illinois, hasn’t disclosed how much offshore cash it intended to use to finance the Shire purchase. As of the second quarter of this year, the company held about $10.2 billion in cash and equivalents, according to data compiled by Bloomberg, which analysts, including Jeffrey Holford at Jefferies LLC in New York, estimate is mostly held outside the U.S.
The overall impact of the new U.S. rules on inversion deals isn’t yet clear. Pfizer Inc. (PFE), the largest U.S. drugmaker, is still seeking acquisition targets that would allow it to move out of the U.S., and recently approached Actavis Plc (ACT) about a combination, people familiar with the matter said earlier this week. Canadian coffee-and-doughnuts chain Tim Hortons Inc. (THI), which is being acquired by Burger King Worldwide Inc. (BKW) in an inversion merger, has said the deal will proceed despite the restrictions.
So far, the U.S. has stopped short of targeting the most lucrative elements of inversion deals such as so-called “earnings stripping,” which allows companies to lower taxable U.S. profits by shifting them to foreign subsidiaries. Attempts to introduce stricter measures may have to wait for comprehensive tax reform legislation in Congress, where Republicans and Democrats have been unable to agree on a way forward.
AbbVie Inc. (ABBV) is examining plans to raise additional financing to complete its takeover of Shire Plc (SHP), after U.S. officials imposed new obstacles to so-called tax inversion deals, people with knowledge of the matter said.
AbbVie may seek to borrow as much as $7 billion more than it originally anticipated because of new restrictions on using cash held offshore, two of the people said, asking not to be identified discussing a private matter. The deliberations are at an early stage, and are part of a comprehensive review of the Shire transaction’s structure after U.S. Treasury Secretary Jack Lew announced measures to make inversions more difficult this week, the people said.
President Barack Obama’s administration is looking at ways to halt a wave of acquisitions that allow U.S. companies to move their legal address overseas, potentially eroding the corporate tax base. The rules imposed this week, which Lew said are within the powers of the executive branch to enact without Congressional legislation, will make it more difficult for U.S. companies to finance inversion deals by using cash they hold overseas, beyond the reach of American taxes. While offshore money can still be used under the new regulations, it would be subject to a 35 percent tax rate.
No final decision on how to proceed has been made by AbbVie, which is still waiting for details on how the Treasury rules will be implemented and examining several scenarios, the people said. The company is working with advisers to gauge the cost of any increased borrowing, as well as its impact on credit ratings and the deal overall, one of the people added.
A spokeswoman for AbbVie said in an e-mail that rumors of AbbVie seeking additional financing are untrue. She declined to comment on whether the company would stand by the deal or walk away. A spokeswoman for Shire declined to comment.
AbbVie is still committed to completing the $55 billion merger, the people said. In addition to tax benefits, AbbVie would get Shire’s drugs for attention-deficit disorder and rare diseases, diversifying its own portfolio.
The measures announced by Lew on Sept. 22 impose curbs on loans or cash transfers from offshore subsidiaries to a new foreign parent -- which AbbVie would create by setting up a U.K.-domiciled company after buying Shire. The headline rate of tax on U.S. corporate earnings is 40 percent, compared with 21 percent in the U.K.
AbbVie, which is based in North Chicago, Illinois, hasn’t disclosed how much offshore cash it intended to use to finance the Shire purchase. As of the second quarter of this year, the company held about $10.2 billion in cash and equivalents, according to data compiled by Bloomberg, which analysts, including Jeffrey Holford at Jefferies LLC in New York, estimate is mostly held outside the U.S.
The overall impact of the new U.S. rules on inversion deals isn’t yet clear. Pfizer Inc. (PFE), the largest U.S. drugmaker, is still seeking acquisition targets that would allow it to move out of the U.S., and recently approached Actavis Plc (ACT) about a combination, people familiar with the matter said earlier this week. Canadian coffee-and-doughnuts chain Tim Hortons Inc. (THI), which is being acquired by Burger King Worldwide Inc. (BKW) in an inversion merger, has said the deal will proceed despite the restrictions.
So far, the U.S. has stopped short of targeting the most lucrative elements of inversion deals such as so-called “earnings stripping,” which allows companies to lower taxable U.S. profits by shifting them to foreign subsidiaries. Attempts to introduce stricter measures may have to wait for comprehensive tax reform legislation in Congress, where Republicans and Democrats have been unable to agree on a way forward.
Abbvie Might Walk Away From Shire Deal
Mindy turkewitz
How can Mindy Turkewitz keep fooling everyone? Lazy and unknowledgeable yet she keeps getting great evaluations??? Someone should Start looking at the time she gets into territory. Most of us reps r finishing our day!! Unbelievable!!!
Mindy turkewitz
Fast-Acting Erectile Dysfunction Pill Gets FDA OK
NewsmaxHealth
Fast-Acting Erectile Dysfunction Pill Gets FDA OK
Thursday, September 18, 2014 08:26 AM
*
An erectile dysfunction drug that reduces by half the time patients need to take the pill before sexual activity has been approved by the U.S. Food and Drug Administration.
Developed by Auxilium Pharmaceuticals Inc and Vivus Incs, the drug, Stendra, is the first FDA-approved erectile dysfunction drug that can be taken about 15 minutes prior to sexual activity.
Pfizer Inc's blockbuster erectile dysfunction drug, Viagra, can be taken about an hour before sex.
Editor's Note: Prostate Cancer Is Almost Epidemic - Prevent It
Stendra, first approved in 2012, is available in multiple dosages (50 mg, 100 mg and 200 mg tablets) and may be taken with or without food and moderate alcohol consumption (up to three drinks), the companies said on Thursday.
It belongs to a class of drugs called phosphodiesterase type 5 inhibitors, which are used to help increase blood flow to the penis.
Vivus owns the worldwide development and commercial rights to Stendra for use in sexual dysfunction, with the exception of certain Asian countries in the Pacific Rim.
Auxilium has exclusive marketing rights to Stendra in the United States and Canada, while Sanofi SA holds a license to commercialize it in Africa, the Middle East, Turkey, and the Commonwealth of Independent States including Russia.
The drug is sold as Spedra in the European Union.
*
Auxilium said on Wednesday it would not withdraw its offer to buy Canadian eye drug maker QLT Inc and adopted a poison pill, a day after receiving an unsolicited buyout offer from Endo International Plc.
Fast-Acting Erectile Dysfunction Pill Gets FDA OK
Thursday, September 18, 2014 08:26 AM
*
An erectile dysfunction drug that reduces by half the time patients need to take the pill before sexual activity has been approved by the U.S. Food and Drug Administration.
Developed by Auxilium Pharmaceuticals Inc and Vivus Incs, the drug, Stendra, is the first FDA-approved erectile dysfunction drug that can be taken about 15 minutes prior to sexual activity.
Pfizer Inc's blockbuster erectile dysfunction drug, Viagra, can be taken about an hour before sex.
Editor's Note: Prostate Cancer Is Almost Epidemic - Prevent It
Stendra, first approved in 2012, is available in multiple dosages (50 mg, 100 mg and 200 mg tablets) and may be taken with or without food and moderate alcohol consumption (up to three drinks), the companies said on Thursday.
It belongs to a class of drugs called phosphodiesterase type 5 inhibitors, which are used to help increase blood flow to the penis.
Vivus owns the worldwide development and commercial rights to Stendra for use in sexual dysfunction, with the exception of certain Asian countries in the Pacific Rim.
Auxilium has exclusive marketing rights to Stendra in the United States and Canada, while Sanofi SA holds a license to commercialize it in Africa, the Middle East, Turkey, and the Commonwealth of Independent States including Russia.
The drug is sold as Spedra in the European Union.
*
Auxilium said on Wednesday it would not withdraw its offer to buy Canadian eye drug maker QLT Inc and adopted a poison pill, a day after receiving an unsolicited buyout offer from Endo International Plc.
Fast-Acting Erectile Dysfunction Pill Gets FDA OK
Pfizer Oncology HQ Team Sucks
What a pathetic group of misfits and losers!
Pfizer Oncology HQ Team Sucks
Company woes as long as VP of sales as at helm!
As long as AP remains in control the company is not to be trusted. He has gone from distributors to direct to distributors to direct several times. He has even been know, as many small crap company's have, to carve out territory on company reps and distributors routinely for idle promises. He has a long history of incompetence but has the ear of the controlling stakeholders. Beware of this one! There are many other very good products and opportunities available without putting yourself thru the heartaches!
Company woes as long as VP of sales as at helm!
samedi 27 septembre 2014
Open Positions!
Are employee referrals the best way to be guaranteed an interview or does Shire use a specific recruiting company? I would appreciate any information you can provide. Thanks in advance!
Open Positions!
Shane Foley
What happens to Foleys crew of 25 year old reps when STJ gets MRI ? Back to delivering pizzas. Stackpole is going to crush the little bugs. Well, Foley turns 60 next year . He is all set.
Shane Foley
Possible Black box removal for Chantix
New FDA label bolsters safety case for Chantix
Associated Press
By MATTHEW PERRONE Sep 24, 2014 5:42 PM
Thoughts?
Associated Press
By MATTHEW PERRONE Sep 24, 2014 5:42 PM
Thoughts?
Possible Black box removal for Chantix
Actavis will buy Pfizer after Salix and Allergan deals are struck
Actavis is looking to buy up Salix AND Allergan to make themselves a bigger company to purchase Pfizer, since tax inversion cannot be struck. That's right, we will be the largest pharmaceutical company in the world when all is said and done. Enjoy the ride, it will be bumpy at times, but we will prevail.
Even with Tax Inversion, the Pfizer thing was unlikely to happen...too heavily focused on the generics..hated to burst your bubbles but the pfizer thing was never going to happen...too heavily focused on the generics still and the value isn't there for Pfizer. AZ still the favorite..maybe GSK. could be wrong but I am a FSR1 rep and that makes me smarter than most…if Pfizer can't purchase AZ or GSK, we will buy them after we buy Salix and Allergan.
Even with Tax Inversion, the Pfizer thing was unlikely to happen...too heavily focused on the generics..hated to burst your bubbles but the pfizer thing was never going to happen...too heavily focused on the generics still and the value isn't there for Pfizer. AZ still the favorite..maybe GSK. could be wrong but I am a FSR1 rep and that makes me smarter than most…if Pfizer can't purchase AZ or GSK, we will buy them after we buy Salix and Allergan.
Actavis will buy Pfizer after Salix and Allergan deals are struck
Actavis will buy Pfizer after Salix and Aligran deals are struck
Actavis is looking to buy up Salix AND Allergan to make themselves a bigger company to purchase Pfizer, since tax inversion cannot be struck. That's right, we will be the largest pharmaceutical company in the world when all is said and done. Enjoy the ride, it will be bumpy at times, but we will prevail.
Even with Tax Inversion, the Pfizer thing was unlikely to happen...too heavily focused on the generics..hated to burst your bubbles but the pfizer thing was never going to happen...too heavily focused on the generics still and the value isn't there for Pfizer. AZ still the favorite..maybe GSK. could be wrong but I am a FSR1 rep and that makes me smarter than most…if Pfizer can't purchase AZ or GSK, we will buy them after we buy Salix and Alirgan.
Even with Tax Inversion, the Pfizer thing was unlikely to happen...too heavily focused on the generics..hated to burst your bubbles but the pfizer thing was never going to happen...too heavily focused on the generics still and the value isn't there for Pfizer. AZ still the favorite..maybe GSK. could be wrong but I am a FSR1 rep and that makes me smarter than most…if Pfizer can't purchase AZ or GSK, we will buy them after we buy Salix and Alirgan.
Actavis will buy Pfizer after Salix and Aligran deals are struck
Shake up
BH leaves and now JL. Why did DaveK get marketing role when CL has connections to Vijay?
Shake up
Successes
Is any territory doing well with Zohydro?
I keep reading about all the bad press, but I'm wondering if specific parts of the US are doing well with the launch.
I keep reading about all the bad press, but I'm wondering if specific parts of the US are doing well with the launch.
Successes
MS is best part time job in America!
Why all the complaints on MSBU? We work maybe 10 hours per week? Access to Tier 1 Neuros is non existent even with a lunch, unless they are a speaker. We fake most of our calls. I hit the gym by 1 pm or watch movies. This job affords me great freedom and I get paid a 6 figures for working 10 hours per week plus almost free car. Why the complaints?
MS is best part time job in America!
Toxicology Isn't Dead
I see many talking about urine toxicology being dead. That's not close to true, and if you have a decent network of docs doing pain management, psych management, family practices, etc., hit me up.
Our labs have been built off of urine toxicology and our reps are killing it.
Our owners are very hands on, and we are the most rep-friendly company around as far as percentage points. Lots of markets wide open, so if interested, text or call at 903.277.6089 for more details.
Chris
Our labs have been built off of urine toxicology and our reps are killing it.
Our owners are very hands on, and we are the most rep-friendly company around as far as percentage points. Lots of markets wide open, so if interested, text or call at 903.277.6089 for more details.
Chris
Toxicology Isn't Dead
AZ MEDI still killin it !!
In the case of AstraZeneca's combination, six out of 24 advanced lung cancer patients had adverse events rated as serious, or grade 3/4, and three had events that led to discontinuation of treatment. There was one treatment-related death.
AZ MEDI still killin it !!
Most stupid things reps have had doctors do!
You got it, some reps will wrap their fav docs around their fingers!
Tall tales, fibs and sob stories can get some of them to do plenty!
Tall tales, fibs and sob stories can get some of them to do plenty!
Most stupid things reps have had doctors do!
Generic Butrans
Actavis confirms patent challenge for generic Butrans
September 26, 2014 |
September 26, 2014 |
Generic Butrans
vendredi 26 septembre 2014
Deirdre's This is War Comment
I'm one who never gets to upset and pretty much goes with the flow. However when I was alerted to DC's comment in the WSJ of "this is war" I about lost it. How can someone who has reached her position be so out of touch with reality?
We have GSK employees whose lives have been ever changed due to injury or post traumatic stress syndrome of a family member. How in the world does that relate to the pharma world. Maybe that was your position at Lilly but here at GSK we were always about putting the patient and our employees first. That was until you came along.
While I'm so upset about the GSK family that you so disrupted I cannot get over your lack of professionalism and your poor choice of words to once again move your agenda forward.
DC you owe many GSK employees and their families and apology for such a comment. I've been in this industry for a long time. Not once did the idea of WAR ever cross any of our minds when it came to our jobs.
Go talk to family members who have spouses and children who are and have participated in a real WAR before you make such an inconsiderate comment.
No wonder GSK US is failing so miserably. All anyone had to do is look at our senior leader who implemented her agenda which has failed miserably.
DC how dare you compare a pharma job to what our brave military men and woman do everyday.
I've always lived by what have you done today to feel proud? DC can you tell us what your proud of? I dare u to go take a PF test and get a scorecard that makes no sense.
Really pharma being compared to WAR?
We have GSK employees whose lives have been ever changed due to injury or post traumatic stress syndrome of a family member. How in the world does that relate to the pharma world. Maybe that was your position at Lilly but here at GSK we were always about putting the patient and our employees first. That was until you came along.
While I'm so upset about the GSK family that you so disrupted I cannot get over your lack of professionalism and your poor choice of words to once again move your agenda forward.
DC you owe many GSK employees and their families and apology for such a comment. I've been in this industry for a long time. Not once did the idea of WAR ever cross any of our minds when it came to our jobs.
Go talk to family members who have spouses and children who are and have participated in a real WAR before you make such an inconsiderate comment.
No wonder GSK US is failing so miserably. All anyone had to do is look at our senior leader who implemented her agenda which has failed miserably.
DC how dare you compare a pharma job to what our brave military men and woman do everyday.
I've always lived by what have you done today to feel proud? DC can you tell us what your proud of? I dare u to go take a PF test and get a scorecard that makes no sense.
Really pharma being compared to WAR?
Deirdre's This is War Comment
I hope my KAM doesn't get an ABL position!!
My KAM is such a douche bag, lazy, high opinion of himself for no reason that I can see. If he gets one of the ABL jobs and I end up working for him I'll probably shoot myself!!
I hope my KAM doesn't get an ABL position!!
Warning
T. Rowe Price, which said it held 5.4 percent of Allergan shares as of June 30, Friday followed 1.3 percent holder Pentwater Capital Management in voicing dismay over Allergan's reported potential acquisition of Salix Pharmaceuticals.
Warning
Actavis
Face the facts. Actavis will buy Allergan soon. Investors have teamed together to axe the Salix deal and the days of R&D are done.
Actavis
T Rowe Price Calls for Meeting- Urges Shareholder Vote
September 26, 2014, 2:40 P.M. ET
.
T.Rowe Calls For Shareholder Vote On Allergan’s Plans Too
By Teresa Rivas
Late Thursday, Pentwater Capital Management publicly denounced Allergan’s (AGN) potential acquisition of Salix Pharmaceuticals (SLXP) without a shareholder vote. The firm joins activist investor Bill Ackman, who has also threatened a lawsuit if Allergan doesn’t give shareholders a voice about acquisition, which he opposes, preferring instead to have Allergan bought by Valeant Pharmaceuticals (VRX).
Now T. Rowe Price (TROW) is also coming out against the move. In a statement released this afternoon the firm said it has been watching the actions of Allergan’s board “with growing concern”:
In our view, the issues to be voted on at the special meeting of shareholders on December 18 are of such importance that they impose a special duty on the Board to refrain from approving any significant, irreversible commitments by the company between now and then unless shareholders are offered the opportunity to vote on them. We believe this should apply even in the event of all-cash acquisitions that do not ordinarily require a shareholder vote.
Although Salix isn’t named, presumably the “any significant, irreversible commitments” language likely refers to the firm, as Allergan was said to be planning an all-cash offer.
.
T.Rowe Calls For Shareholder Vote On Allergan’s Plans Too
By Teresa Rivas
Late Thursday, Pentwater Capital Management publicly denounced Allergan’s (AGN) potential acquisition of Salix Pharmaceuticals (SLXP) without a shareholder vote. The firm joins activist investor Bill Ackman, who has also threatened a lawsuit if Allergan doesn’t give shareholders a voice about acquisition, which he opposes, preferring instead to have Allergan bought by Valeant Pharmaceuticals (VRX).
Now T. Rowe Price (TROW) is also coming out against the move. In a statement released this afternoon the firm said it has been watching the actions of Allergan’s board “with growing concern”:
In our view, the issues to be voted on at the special meeting of shareholders on December 18 are of such importance that they impose a special duty on the Board to refrain from approving any significant, irreversible commitments by the company between now and then unless shareholders are offered the opportunity to vote on them. We believe this should apply even in the event of all-cash acquisitions that do not ordinarily require a shareholder vote.
Although Salix isn’t named, presumably the “any significant, irreversible commitments” language likely refers to the firm, as Allergan was said to be planning an all-cash offer.
T Rowe Price Calls for Meeting- Urges Shareholder Vote
Final Payout...?
I voluntarily left MNK on August 22nd, rather than waiting around to get "laid off". I am still waiting for my last paycheck, over a month later. I refuse to get closed out until I am paid the money I am legally owed. I called HR twice and told them I will not return their electronics and other stuff until I am paid. No one answered the phone or called me back. I filed a wage claim today, which places a financial penalty on MNK for each day I have not been paid, because there is no just cause for non-payment. I am wondering if any other former reps are experiencing the same. BTW, I didn't have a car to turn in as it was in an accident a week before I quit.
Final Payout...?
ID Positions
I am in medical devices I was wondering How can you sell this drug if you do not leave samples.
How the doctors evaluate your products?
How the doctors evaluate your products?
ID Positions
Seriously? Are you over 30 and in primary car sales?
Wow. How do you do it? How do you wake up and say, I'm going to drive around and drop off samples and bring lunches to fatties? It's it embarrassing? Who do your kids look up to?
Seriously? Are you over 30 and in primary car sales?
peri-implantitis remedy?
I am hearing from some folks in the EU as well as on the US east coast that there is some new simple quick thing for putting on affected implants? Anyone know anything about this? Apparently it may be available in the US? Supposedly already available in some of the EU countries and less than 100 euros.
peri-implantitis remedy?
VTP- can we talk money? ARI
Hi:
So..my lump sum seems huge...but I think they are taking 40% taxes. And my understanding is that I am not getting my stocks NOW but in the future when they vest and only the ones vest prior to April 2015. On my breakdown I did not see the pay for the vacation time that they said they were paying out. Does anyone know how that will be paid? In a separate check? Actually I can ask HR..but I figured a new topic and maybe I will learn something else I don't know. Are people rolling over their 401Ks or leaving them?
In Rhode Island we can apply for unemployment today. I heard that we should do that within 5 days of leaving (just a reminder).
So..my lump sum seems huge...but I think they are taking 40% taxes. And my understanding is that I am not getting my stocks NOW but in the future when they vest and only the ones vest prior to April 2015. On my breakdown I did not see the pay for the vacation time that they said they were paying out. Does anyone know how that will be paid? In a separate check? Actually I can ask HR..but I figured a new topic and maybe I will learn something else I don't know. Are people rolling over their 401Ks or leaving them?
In Rhode Island we can apply for unemployment today. I heard that we should do that within 5 days of leaving (just a reminder).
VTP- can we talk money? ARI
Reduction in separation pay formula
The current separation pay policy is 2 weeks for every full year of service with certain minimums depending on the position classification. The next shoe to drop following the changes to retirement medical and the pension is a change in this policy to one week for every full year of service. With the upcoming RIF's, mergers, and divestitures, J&J is seeing viewing their policy as overly competitive and will need to reduce the costs associated with upcoming changes in 2015. Be prepared that the financial bridge provided while you seek other employment will not be as generous as it once was. Welcome to the new J&J.
Reduction in separation pay formula
Respiratory Sales
Interviewing for a respiratory sales position. Is this considered primary care or specialty? What is the salary range for experienced rep? Any new products coming out soon?
Respiratory Sales
jeudi 25 septembre 2014
Resolution Clip
Guys, better start pulling out all the bully and fear tactics, because your business is going out the door. Can you say, inferior product? enjoy.
Resolution Clip
Out of cash?
Is it true? I hear commissions for q3 are going to be delayed due to cash problems
Out of cash?
Done deal breaking news
TMZ.com is reporting a three way merger. Salix-Panera-AC Moore (for HR arts and crafts.)
Done deal breaking news
Thursday Nite Giants TV Ratings
I predict very low ratings on the game. Everyone is out getting their blood drawn at Quest Diagnostics.
Thursday Nite Giants TV Ratings
Durata already selling off-label?
Reps pushing single infusion and skip the 2nd dose. My sources are telling me the FDA has already been notified.
Durata digging themselves a hole, early.
Durata digging themselves a hole, early.
Durata already selling off-label?
Patterson 1.5 hr Assessment Test
Can anyone give any insight to the in office assessment test? Just looking for some question examples, what some of your answers were. Never had to take a test like this so just curious.
If you have an opinion (good or bad) on Patterson, then just don't answer, because I really don't care. I have read all I need to and most of it just funny.
TIA
If you have an opinion (good or bad) on Patterson, then just don't answer, because I really don't care. I have read all I need to and most of it just funny.
TIA
Patterson 1.5 hr Assessment Test
Intuniv
Happy all around here at shire except for this freakin intuniv goal whaaaaaa!! For goodness sakes can we get a reduction in this?? Hello - generic in 3 months, or am I missing something? Why do you want is to push (and that's what it takes to get even close to 100%) push intuniv use even more on writers and to reach 100% you'll also need to try to gain new writers.nits a great product but soon going to be an enemy. We lost United and goals didn't even drop by the # of United scripts due to an "epic fail" by corp accounts not keeping int on united formulary: thanks for making us pay for your mess up.
Rant over
Rant over
Intuniv
District Meetings
Why are we having district meetings? Is this to get us out of the field with no samples?
District Meetings
Nice Professional Interview Process
So, I get an email telling me to take a 10 minute video of myself, answering questions from the brain trust at Takeda HR...
and then submit it, as a preliminary interview...
wtf...are you people giving out gold bars as bonus checks or something?
You are Takeda, right? You are pharmaceutical sales, right? Wow. How strange an industry you are in. How strange of a company Takeda now is...
go F yourself!
and then submit it, as a preliminary interview...
wtf...are you people giving out gold bars as bonus checks or something?
You are Takeda, right? You are pharmaceutical sales, right? Wow. How strange an industry you are in. How strange of a company Takeda now is...
go F yourself!
Nice Professional Interview Process
Important stuff to remember!
Never kiss your honey
When your nose is runny
You may think it's funny
But it's snot
That is all
When your nose is runny
You may think it's funny
But it's snot
That is all
Important stuff to remember!
BONUS FRAUD
So as a rep I lost $1K due to GSK losing money. OK--we did..seems fair...but
THE MANAGERS RECEIVED 100% OF THEIR BONUS FOR THIS SECTION!!!!!
HOW IS THIS FAIR???????
THE MANAGERS RECEIVED 100% OF THEIR BONUS FOR THIS SECTION!!!!!
HOW IS THIS FAIR???????
BONUS FRAUD
Uh oh. They've begun
As predicted by engineers at the other two CRM companies, the DF4 design at Big Blue has begun to fail. 2 fractures seen. Less than a year implanted. And awaaaaay we go!
Uh oh. They've begun
Why are folks so nervous about layoffs here?
Our Upper Management Leadership team, specifically DM, said no cuts were happening after the meeting. Go disrupt, be a catalyst, and Be Better.
Why are folks so nervous about layoffs here?
Who is worst HR rep
my vote
Niel Britain was Head of HR at Novartis franchise but was demoted for not calibrating, retaliating and personally attacking VPs. Demoted to AD even below director. Worst HR guy from North Carolinga. Failed operations.
you
Niel Britain was Head of HR at Novartis franchise but was demoted for not calibrating, retaliating and personally attacking VPs. Demoted to AD even below director. Worst HR guy from North Carolinga. Failed operations.
you
Who is worst HR rep
Warning ; Worst rep from Novartis joining
WARNING. Niel Britain was Head of HR at Novartis franchise but was demoted for not calibrating, retaliating and personally attacking VPs. Demoted to AD even below director. Worst HR guy from North Carolinga. Failed operations.
you were warned
you were warned
Warning ; Worst
rep from Novartis joining
death knell
Unfortunately the combination of Medicare,Congress, PPSC, Lincare and Rotech with all of their underhanded dealings and practices have doomed DME as we have known it. The ones who suffer most are the seniors who deserve better.
death knell
mercredi 24 septembre 2014
Please hire the right managers!!
Npc please hire the right managers and not just who kisses leaderships ass. There are so many that need to go and now is your chance to get them out. There are a few good ones and one can only hope you hang on to them. You'd think this company would take the opportunity to clean some house after all the law suits and crooked hr. Wishful thinking
Please hire the right managers!!
I have a woody!
apparently a leader of LifeCell has a shelf life of 1 - 1.5 years.... way to go Joe! You are doing a great job... watch as the LC turnover rate climbs to a rate you have never seen. This is not SA... this is real Pharma Country where jobs are plenty for talent. So long....
I have a woody!
HSAM's Call's Friday 9-26-14
Does anyone know what these calls may look like this Friday?
HSAM's Call's Friday 9-26-14
DMs, Reps, and Doctors
Is it considered unethical for a DM or a Rep to have an affair with a doctor? What are the ramifications? Is this type of thing common in the field?
DMs, Reps, and Doctors
Jackass Candidates
Recruiters, share your horror stories about your nightmare candidates.
Jackass Candidates
Managed Care Group getting EXPOSED
It's one thing when you have the best in class oncology product to show superior managed care access.
It's another when you actually have to produce in a competitive market.
A lot of people on Wall Street are depending on you to deliver and you are failing at every turn.
Humana
Prime
BCBS
Aetna
Cigna
You need to show a win somewhere, other than Tricare.
Look, we want the stock to rise. You don't need to put your effort on the oncology side of the house. You think you are winning there, but the product is a winner to begin with.
It's another when you actually have to produce in a competitive market.
A lot of people on Wall Street are depending on you to deliver and you are failing at every turn.
Humana
Prime
BCBS
Aetna
Cigna
You need to show a win somewhere, other than Tricare.
Look, we want the stock to rise. You don't need to put your effort on the oncology side of the house. You think you are winning there, but the product is a winner to begin with.
Managed Care Group getting EXPOSED
Do women receive equal pay at Quest
I heard from several women that the compensation is not equal compared to men. Does anyone know for sure?
Do women receive equal pay at Quest
On Patrol today
Just to let you all know, I will be on patrol of the board today, as usual. I am ready to throw a few zingers at any of the PR agents that don't agree with me and I will work hard to come up with some new threads to tell you how much I hate it here.
On Patrol today
New trucks
I have heard the company has new trucks on order for after the first of the year!
New trucks
We are #1
Wow. 44 people viewing on CP. Busiest board on the site. At least people are noticing Shionogi someplace. Even if it's not the physicians we call on with a product nobody wants.
We are #1
Was there any question who benefits from MDT deal? --- this should settle it
The folks in charge change the period in which they get Golden Parachutes from 12 months to 24 months after Medtronic buy-out.
For Real. Unreal.
It's on the website, the filing for 9-23-14, this link might work:
http://ift.tt/1ChN6j1
Covidien execs are using this buyout as a personal enrichment scheme ---- and Medtronic has barely scratched the surface on what this will cost them.
For Real. Unreal.
It's on the website, the filing for 9-23-14, this link might work:
http://ift.tt/1ChN6j1
Covidien execs are using this buyout as a personal enrichment scheme ---- and Medtronic has barely scratched the surface on what this will cost them.
Was there any question who benefits from MDT deal? --- this should settle it
Enter Activis
Out with Allergan- they won't pay us the premium that we want and want a back out clause in the deal. Activis has now sat down at the table...
Things are going to get interesting. FYI if Activis does purchase us plan on getting a severance- heads will roll..................
Things are going to get interesting. FYI if Activis does purchase us plan on getting a severance- heads will roll..................
Enter Activis
Time to cut the co-pay coupons, guys!
Did Someone say Kickbacks? HHS Warns About Medicare Part D Coupons
Brand-name drug makers regularly use coupons to woo consumers and boost sales. But inducing Medicare Part D beneficiaries to use coupons is illegal. So drug makers are supposed to use safeguards to ensure these consumers do not use coupons to obtain prescription medicines.
But a new report finds the efforts are lacking. As many as 7% of seniors report using coupons to purchase prescription drugs, which amounts to some 2 million people relying on coupons when they should not be able to do so. There are about 36 million Medicare Part D beneficiaries.
The implication is that Medicare is paying too much for some medicines. Why? Coupons may increase costs if these encourage consumers to purchase more expensive brand-name drugs instead of lower-cost generics. Brand-name drug makers, you may recall, have been increasingly relying on coupons to sustain market share.
The report, which was conducted by the Office of the Inspector General of the U.S. Department of Health and Human Services, did not provide an estimate of what coupons are costing Medicare. But the agency did note it is considered to be a kickback to entice consumers to use coupons to purchase medicines that are paid for by Medicare Part D or other federal health-care programs.
This sort of activity would constitute a kickback, which the OIG highlighted in a ‘special advisory bulletin’ issued late last week to remind drug makers and pharmacies. A spokeswoman for the Pharmaceutical Research and Manufacturers of America, the trade group for brand-name drug makers, says “we are in the process of reviewing the OIG report and special advisory bulletin on copayment coupon use.”
The OIG surveyed 30 drug makers that manufacture the top 100 Part D brand-name drugs for which coupons are offered and generate the highest Medicare expenditures. The agency also reviewed certain safeguards used by drug makers and interviewed staff at various organizations involved in pharmacy claims transactions.
So why is there a problem? For instance, the OIG found that nearly all of the coupons obtained had a printed notice, but only 80% had a comparable notice on the coupon web site. Moreover, 75% had an eligibility question online or over the phone. But only 3% had a tracking mechanism on their web sites to prevent a patient from changing an answer to the eligibility question to obtain the coupon.
Approximately two-thirds of the drug makers surveyed provided notices to pharmacists for at least one of the coupon formats they offer. Put another way, one third did not. And of those drug makers that did provide notices, the OIG found that of 40 coupons obtained and reviewed, 42% did not have notices with specific language directed to pharmacists. Pharmacists are busy and so added language can help.
Here is another inadequate feature of the coupons – the OIG found that manufacturer notices to patients and pharmacists “only communicate information stipulating the terms and conditions of copayment coupons. These notices cannot necessarily stop coupons from being processed to purchase drugs paid for by Federal health care programs,” the OIG report states.
Also, the behind-the-scenes method for processing insurance claims may not stop all coupons from being processed for drugs paid for by Medicare Part D because drug makers cannot accurately identify a consumer’s enrollment status. The reason is that drug makers use proxy data to identify Part D enrollees, since they are prohibited for privacy reasons from using actual data. But this is unreliable.
OIG recommends that the Centers for Medicare & Medicaid Services find a way to work with drug makers to improve the reliability of pharmacy claims and verify enrollment. CMS should also explore ways to make coupons universally identifiable. The OIG got no argument from the U.S. Department of Health and Human Service. In an attached reply, HHS Secretary Marilyn Tavenner agreed with all of the recommendations.
Brand-name drug makers regularly use coupons to woo consumers and boost sales. But inducing Medicare Part D beneficiaries to use coupons is illegal. So drug makers are supposed to use safeguards to ensure these consumers do not use coupons to obtain prescription medicines.
But a new report finds the efforts are lacking. As many as 7% of seniors report using coupons to purchase prescription drugs, which amounts to some 2 million people relying on coupons when they should not be able to do so. There are about 36 million Medicare Part D beneficiaries.
The implication is that Medicare is paying too much for some medicines. Why? Coupons may increase costs if these encourage consumers to purchase more expensive brand-name drugs instead of lower-cost generics. Brand-name drug makers, you may recall, have been increasingly relying on coupons to sustain market share.
The report, which was conducted by the Office of the Inspector General of the U.S. Department of Health and Human Services, did not provide an estimate of what coupons are costing Medicare. But the agency did note it is considered to be a kickback to entice consumers to use coupons to purchase medicines that are paid for by Medicare Part D or other federal health-care programs.
This sort of activity would constitute a kickback, which the OIG highlighted in a ‘special advisory bulletin’ issued late last week to remind drug makers and pharmacies. A spokeswoman for the Pharmaceutical Research and Manufacturers of America, the trade group for brand-name drug makers, says “we are in the process of reviewing the OIG report and special advisory bulletin on copayment coupon use.”
The OIG surveyed 30 drug makers that manufacture the top 100 Part D brand-name drugs for which coupons are offered and generate the highest Medicare expenditures. The agency also reviewed certain safeguards used by drug makers and interviewed staff at various organizations involved in pharmacy claims transactions.
So why is there a problem? For instance, the OIG found that nearly all of the coupons obtained had a printed notice, but only 80% had a comparable notice on the coupon web site. Moreover, 75% had an eligibility question online or over the phone. But only 3% had a tracking mechanism on their web sites to prevent a patient from changing an answer to the eligibility question to obtain the coupon.
Approximately two-thirds of the drug makers surveyed provided notices to pharmacists for at least one of the coupon formats they offer. Put another way, one third did not. And of those drug makers that did provide notices, the OIG found that of 40 coupons obtained and reviewed, 42% did not have notices with specific language directed to pharmacists. Pharmacists are busy and so added language can help.
Here is another inadequate feature of the coupons – the OIG found that manufacturer notices to patients and pharmacists “only communicate information stipulating the terms and conditions of copayment coupons. These notices cannot necessarily stop coupons from being processed to purchase drugs paid for by Federal health care programs,” the OIG report states.
Also, the behind-the-scenes method for processing insurance claims may not stop all coupons from being processed for drugs paid for by Medicare Part D because drug makers cannot accurately identify a consumer’s enrollment status. The reason is that drug makers use proxy data to identify Part D enrollees, since they are prohibited for privacy reasons from using actual data. But this is unreliable.
OIG recommends that the Centers for Medicare & Medicaid Services find a way to work with drug makers to improve the reliability of pharmacy claims and verify enrollment. CMS should also explore ways to make coupons universally identifiable. The OIG got no argument from the U.S. Department of Health and Human Service. In an attached reply, HHS Secretary Marilyn Tavenner agreed with all of the recommendations.
Time to cut the co-pay coupons, guys!
Shady
Was contacted by a regional manager. Spoke for a 1/2 hr on Thursday, 1:15 on Friday. Told me to stop looking for other positions. Met on Monday, acted like we had never spoken. During face-to-face, asked me how I would "handle promoting a product that hadn't been approved by the FDA for the use" they wanted it. Told him I wouldn't promote off-label. Didn't get moved on to the final interview with their NSD. I guess I came up *short* of the hard *Knox* it takes at Romark, but I *ville* survive.
Shady
mardi 23 septembre 2014
Some of the moronic CP post make me support AFP
AFP is tough. I get it. But some of the childish post here make me want to support some of you getting canned.
Some of the moronic CP post make me support AFP
What are they doing to West Point?
The research labs are being consolidated into a building that is too small for the work at hand. This guarantees zero growth of research at West Point. They are cramming biologists into chemistry labs and they are spending as little money as possible on renovations. They are doing this fast and cheap, like you might do if you were flipping a house. What is the plan?
What are they doing to West Point?
Does this company only hire Temp workers now
I am constantly getting calls from recruiters for this company and when I ask about the type of position it is always a 1 year temporary one with possible renewal for another year.
Does this company only hire temp's now? and do these positions ever go permanent?
(mostly in the Philly and central NJ areas)
Does this company only hire temp's now? and do these positions ever go permanent?
(mostly in the Philly and central NJ areas)
Does this company only hire Temp workers now
Actavis Hits Alltime High $248
Come on Pfizer! Looking forward to a Big stock payout and severence. Bring it!
Actavis Hits Alltime High $248
Merck Contract Bonus Payout
Just wanted to see if anyone had any updates on when the bonus payouts for the Merck contract that ended in June should be received? When I had spoke to the recruiter it was originally mid-September then end of October now I'm hearing it will not be paid until November. Any insight on this situation would be helpful-thanks in advance!
Merck Contract Bonus Payout
Seattle
I'm seeing new research positions opening up in Seattle. Does anyone know what the Seattle site plans are?
Seattle
Shout out to CK in OK
I am a manufacturer rep and don't know where I would be without this woman! Her tenacity and work ethic is something we don't see often from the distribution side...thank you CK!
Shout out to CK in OK
Anyone know what John Chamberlain is doing now?
Wondered what happened to him?
Anyone know what John Chamberlain is doing now?
Game over... AGN price > VRX offer
The gap is closed and reversed. Markets speaking.
Agn= 170.14
VRX = 117.24
117.24 x .83 + 72 = 169
Agn= 170.14
VRX = 117.24
117.24 x .83 + 72 = 169
Game over... AGN price > VRX offer
RIF notification
I love RIF and roll
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me
I love RIF and roll
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me
I love RIF and roll
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me!!!!!!!!!!!!!!
WHO'S WITH ME!!!!!!!!!!!!!!!
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me
I love RIF and roll
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me
I love RIF and roll
So put another dime in the jukebox, baby
I love RIF and roll
So come and take your time and ejaculate with me!!!!!!!!!!!!!!
WHO'S WITH ME!!!!!!!!!!!!!!!
RIF notification
Forest to takeover Salix
That's right, not financially, but literally they will. Actavis just purchased Forest this year, but Forest took over Actavis. Forest management and reps were kept in favor of Actavis legacy reps and management. The Forest CEO is running the show and so on down, the Actavis/Forest acquisition became the "Forest dog-and-pony" show. I wanted to break the news to you all at Salix, this will happen to you to if you allow your leadership to get acquired by Allergan and then Actavis.
Salix management and reps should be worried because it will be Forest legacy running the show for all companies.
Salix management and reps should be worried because it will be Forest legacy running the show for all companies.
Forest to takeover Salix
News
Allergan, the Botox maker fending off a hostile bid by Valeant Pharmaceuticals and Pershing Square Capital Management, had had talks to acquire Salix Pharmaceuticals, another drug maker, according to people briefed on the matter.
If successful, Allergan’s acquisition of Salix would probably derail Valeant and Pershing Square’s $53 billion takeover attempt. It would also mean the end of Salix’s own deal to acquire Cosmo Technologies, the Irish unit of Cosmo Pharmaceuticals of Italy, in a tax inversion deal announced this summer.
But talks between Allergan and Salix continue and could still fall apart, these people said. One person briefed on the matter said the companies still had not come to terms.
And a deal would be a financial reach for Allergan. Salix has a market value of more than $10 billion, and its stock was up 16 percent in after-hours trading following a report in The Wall Street Journal about talks between the companies.
SHARE
SAVE
0 COMMENTS
Show Full Article
Most Popular on NYTimes.com
Airstrikes by U.S. and Allies Hit ISIS Targets in Syria
Rockefellers, Heirs to an Oil Fortune, Will Divest Charity of Fossil Fuels
OP-ED COLUMNIST
Those Lazy Jobless
PAYING TILL IT HURTS
After Surgery, Surprise $117,000 Medical Bill From Doctor He Didn’t Know
U.S. Ramping Up Major Renewal in Nuclear Arms
OP-ED CONTRIBUTOR
Why Poor Students Struggle
White House Intruder’s Past Raises Concern
Weeks of U.S. Strikes Fail to Dislodge ISIS in Iraq
Back to top
Home
World
U.S.
Politics
The Upshot
N.Y. / Region
Business Day
Technology
Sports
Opinion
Science
Health
Arts
Style
Photos
Video
Most Emailed
More
© 2014 The New York Times Company
If successful, Allergan’s acquisition of Salix would probably derail Valeant and Pershing Square’s $53 billion takeover attempt. It would also mean the end of Salix’s own deal to acquire Cosmo Technologies, the Irish unit of Cosmo Pharmaceuticals of Italy, in a tax inversion deal announced this summer.
But talks between Allergan and Salix continue and could still fall apart, these people said. One person briefed on the matter said the companies still had not come to terms.
And a deal would be a financial reach for Allergan. Salix has a market value of more than $10 billion, and its stock was up 16 percent in after-hours trading following a report in The Wall Street Journal about talks between the companies.
SHARE
SAVE
0 COMMENTS
Show Full Article
Most Popular on NYTimes.com
Airstrikes by U.S. and Allies Hit ISIS Targets in Syria
Rockefellers, Heirs to an Oil Fortune, Will Divest Charity of Fossil Fuels
OP-ED COLUMNIST
Those Lazy Jobless
PAYING TILL IT HURTS
After Surgery, Surprise $117,000 Medical Bill From Doctor He Didn’t Know
U.S. Ramping Up Major Renewal in Nuclear Arms
OP-ED CONTRIBUTOR
Why Poor Students Struggle
White House Intruder’s Past Raises Concern
Weeks of U.S. Strikes Fail to Dislodge ISIS in Iraq
Back to top
Home
World
U.S.
Politics
The Upshot
N.Y. / Region
Business Day
Technology
Sports
Opinion
Science
Health
Arts
Style
Photos
Video
Most Emailed
More
© 2014 The New York Times Company
News
US unveils new rules to curb tax inversions
The US Treasury Department announced Monday that it is taking steps under five sections of the country's tax code to make inversions harder and less profitable to accomplish on deals finalised as of September 22. According to the department, the moves "will significantly diminish the ability of inverted companies to escape US taxation," adding that "inversions [will also] no longer make economic sense" to those companies considering mergers.
Specifically, the actions include blocking inverted companies from using so-called "hopscotch" loans to access a foreign subsidiary's earnings without paying US tax on it. Another move seeks to prevent US companies from restructuring their foreign units as a way to access overseas cash reserves tax-free, while yet another aims to close a loophole that currently allows them to transfer cash or property from a "controlled foreign corporation" to the new parent in order to avoid paying US tax.
"This action will significantly diminish the ability of inverted companies to escape US taxation," Treasury Secretary Jacob J. Lew said. "For some companies considering deals, today's action will mean that inversions no longer make economic sense," he added.
Meanwhile, the Treasury Department said it will also make it more difficult for companies to invert by strengthening the requirement that the former owners of the US entity own less than 80 percent of the new combined company. Further, the department pledged to continue looking for other regulatory steps to reduce the benefits of inversions, as well as reviewing tax treaties and other international commitments.
In the wake of Pfizer's unsuccessful attempt to invert by acquiring UK-based AstraZeneca earlier this year, Lew asked Congress to approve tax changes retroactive to May in a bid to stop inversion deals. Last week, Horizon Pharma completed its acquisition of Vidara Therapeutics, which includes moving its corporate address to Ireland, while pending inversion deals include AbbVie's acquisition of Irish-based Shire, as well as a transaction between Mylan and Abbott under which Mylan will relocate to the Netherlands.
Specifically, the actions include blocking inverted companies from using so-called "hopscotch" loans to access a foreign subsidiary's earnings without paying US tax on it. Another move seeks to prevent US companies from restructuring their foreign units as a way to access overseas cash reserves tax-free, while yet another aims to close a loophole that currently allows them to transfer cash or property from a "controlled foreign corporation" to the new parent in order to avoid paying US tax.
"This action will significantly diminish the ability of inverted companies to escape US taxation," Treasury Secretary Jacob J. Lew said. "For some companies considering deals, today's action will mean that inversions no longer make economic sense," he added.
Meanwhile, the Treasury Department said it will also make it more difficult for companies to invert by strengthening the requirement that the former owners of the US entity own less than 80 percent of the new combined company. Further, the department pledged to continue looking for other regulatory steps to reduce the benefits of inversions, as well as reviewing tax treaties and other international commitments.
In the wake of Pfizer's unsuccessful attempt to invert by acquiring UK-based AstraZeneca earlier this year, Lew asked Congress to approve tax changes retroactive to May in a bid to stop inversion deals. Last week, Horizon Pharma completed its acquisition of Vidara Therapeutics, which includes moving its corporate address to Ireland, while pending inversion deals include AbbVie's acquisition of Irish-based Shire, as well as a transaction between Mylan and Abbott under which Mylan will relocate to the Netherlands.
US unveils new rules to curb tax inversions
Losing the Pfizer Acct will end this place
They are THE stategic acct.
They are threatening to pull out of all studies if we don't turn things around.
We are pulling out all stops to do so. Pulling any needed resources away from other accts in order to do so.
It is a no-win situation.
If we save them, unlikely, then it is unsustainable as we can't afford to treat them, or anyone else, this way. And it sets a precedent that we can't afford.
If they leave, which they probably will, the stock tanks.
Big lay offs.
In the meantime things are as horrid as ever - 30% attrition and a nightmare of a corp culture.
Not only does this place suck as an emlployer it's business model blows.
They are threatening to pull out of all studies if we don't turn things around.
We are pulling out all stops to do so. Pulling any needed resources away from other accts in order to do so.
It is a no-win situation.
If we save them, unlikely, then it is unsustainable as we can't afford to treat them, or anyone else, this way. And it sets a precedent that we can't afford.
If they leave, which they probably will, the stock tanks.
Big lay offs.
In the meantime things are as horrid as ever - 30% attrition and a nightmare of a corp culture.
Not only does this place suck as an emlployer it's business model blows.
Losing the Pfizer Acct will end this place
October 1st realignment???
Rumor has it there's a realignment coming October 1st. Please say it's true and please give out voluntary severances. Please!!!!
Anyone have any info?
Anyone have any info?
October 1st realignment???
lundi 22 septembre 2014
Just picked this up
I've only heard good things about LDR but so far no docs using it. Can anyone give me any feedback that is using them
Just picked this up
Classic GSK PR Responses to CafePharma Dissent
Here we GO.....
Common themes:
Dipstick, crybaby, intimidation - "we know who you really are" -berating, questioning intelligence......
What was the number one rule when losing an argument? .I am sure that will be next someplace on this board, asking OP to re-read own definition is close but not exactly. This is to easy....... More more more ...we need more more more...
For your enjoyment excerpt below referencing above:
"Diptstick???? That must be you. No one mentioned EEOC until you did and now that you are trying to spin your little story, we know it is you, crybaby. Only had a cell phone??? Husband?? Tan??? Now you are trying to act like a woman. Yes, you do sound like a "woman", but we know who you really are.
As to your follow up post, read your own definition. Pointing out a fact isn't "advancing". It is clarifying a fact.
Your lack of intelligence is just stunning. How do even manage to dress yourself in the morning?"
Please copy and paste more...We need more!
Common themes:
Dipstick, crybaby, intimidation - "we know who you really are" -berating, questioning intelligence......
What was the number one rule when losing an argument? .I am sure that will be next someplace on this board, asking OP to re-read own definition is close but not exactly. This is to easy....... More more more ...we need more more more...
For your enjoyment excerpt below referencing above:
"Diptstick???? That must be you. No one mentioned EEOC until you did and now that you are trying to spin your little story, we know it is you, crybaby. Only had a cell phone??? Husband?? Tan??? Now you are trying to act like a woman. Yes, you do sound like a "woman", but we know who you really are.
As to your follow up post, read your own definition. Pointing out a fact isn't "advancing". It is clarifying a fact.
Your lack of intelligence is just stunning. How do even manage to dress yourself in the morning?"
Please copy and paste more...We need more!
Classic GSK PR Responses to CafePharma Dissent
Company to go 100% Contract by Dec 1
Ventiv and Quintiles are in current negotiations to win the bid for a contracted sales force. Be on the lookout for openings.
Company to go 100% Contract by Dec 1
It official NPC has finially become the View
Yes, they have succeeded in the total feminization process of NPC as we now have an all female leadership across all 3 BU's and in effect have become pharma's version of The View. Yea ! All wrongs have been righted ! Now we can all sleep well.
It official NPC has finially become the View
BSX New Recall... lethal error
BSX just announced that 27,000 patients will be added to their existing recall of 20,000 patients. Yes, good ol error code 1003 veered its head again. This is the recall where the battery gas gauge appears full....but due to faulty capacitor, it is really empty. This causes a 1003 error code where the device needs to be replaced right away....because it is basically dead. So what is so sneaky about this? The failure occurs in about year 4 of the device. Every year when the device moves from year three to year 4....another expanding list of affected patients enters into recall pool. Next year they will update their recall with 30,000 additional patents. Over 1,500 devices have crapped out in the field so far (Largest failure of any company on record) yet the BSX reps and company just try to hide it under the rug while the poor patients sit with a time bomb.....
BSX: Clean up your act! These are patients! Quit worrying about your stock price.... You brag about longevity....you are a JOKE!
BSX: Clean up your act! These are patients! Quit worrying about your stock price.... You brag about longevity....you are a JOKE!
BSX New Recall... lethal error
Trocar
Does Medtronic/Covidien/Tyco/U.S. Surgical/AutoSuture still offer the Pedi-Port? That thing was awesome!
Trocar
My Otesla rep is a donkey
Wow, could you please send someone into the field with half a brain
My Otesla rep is a donkey
Leadership finally got it somewhat right
I must say that leadership got it right this time. ABLs and KAMS will finally have to sweat a little. Hope they keep the right ones and get rid of those that shouldn't be in those positions in the first place. Smart move to make them interview.
Leadership finally got it somewhat right
Friday payout
Does everyone get some sort of payout on Friday, no matter their integrated score?
Friday payout
Sequent Recall
Heard recall looming. Going to be hit in our area, been on a hot streak.
Sequent Recall
Happy Halloween!
For those who are RIFed, please stop by my mansion for additional food stamps and walmart giftcards for trailor trash. - BB
Happy Halloween!
Mid America Labs Cytology
Heard half the cytology department was let go in Indy. Is this true?
Mid America Labs Cytology
Eric Legangnex keeps missing his goals
I have never seen such an underperforming, disengaged manager. A new model for Novartis?
Eric Legangnex keeps missing his goals
dimanche 21 septembre 2014
FOREST TALENT
"motel six" whatever you think of FRX reps, we are survivors! Yes, that's right, just like the Cockroaches that won't go away. Yeah, maybe we were trained at Motel SIX but, look at the end result. FRX does not go away...Bring it on Pfizer, we motel reps
Will show you what it means to survive DARWINISM! Let's see
Who ends up on top :)
Will show you what it means to survive DARWINISM! Let's see
Who ends up on top :)
FOREST TALENT
Messed Up
I'm sitting here waiting for my integrated rating that will be available in the morning. What makes me sick to my stomach is that all of my hard work, effort and time planning and execution of strategy will have nothing to do with my overall rating which ultimately lead to my worth as a GSK employee. I had little time to study for my assessment and simulation. I am one who did not cheat. I have a good relationship with my customers, I've always been successful even in this new PF testing world. However since moving to this system why I did well or why I didn't is so vague.
My mgr is paid on sales goals, so is our FVP. This is dysfunction at its best.
My mgr is paid on sales goals, so is our FVP. This is dysfunction at its best.
Messed Up
Uh fire those who make these outrageous Osphena goals...?
Why is the sales force always punished by unrealistic and outragous sales projections? Why aren't those who make these retarded $100million goals/projections ever canned?
Its damn stressful to work here right now. The DM per Rep ratio is god awful and unproductive. This place was once awesome to work for but now everyone is stressed out and micromanaged beyond belief because of these goals.
Its damn stressful to work here right now. The DM per Rep ratio is god awful and unproductive. This place was once awesome to work for but now everyone is stressed out and micromanaged beyond belief because of these goals.
Uh fire those who make these outrageous Osphena goals...?
Drama in San Antonio
Whats up with all the drama in San Antonio with the two female reps? I keep hearing crazy stories.
Drama in San Antonio
Let's keep this board medically and industry focused. No slime stock trolls.
The telling nature of these boards leads one to ascertain this is a stock trading forum vs a place to exchange information amount those in the industry.
Let's keep this board medically and industry focused. No slime stock trolls.
RETENTION BONUSES
JT & TR: ever thought of a 12month retention bonus to keep the sales reps? The co has one in place for the Allos reps that were brought on board. Stop the turnover! You talk about how the reps are your biggest asset to the co. Put your $ where your mouth is. Give us a reason to stay!!
RETENTION BONUSES
Diversity
It's great how this company of ours promotes diversity, by putting a bunch of "white" women in senior roles. Many of them totally unfit for the job. Take LA for example. Would be nice to not lie so much regarding the true nature of Cardinal's utter failure at yet another half hearted initiative. Please GB, get off your paper pulpit and put some back into those constant empty words of yours.
Diversity
Monday starts the new world order at NPC
Good luck to all and God Bless everyone.
Monday starts the new world order at NPC
samedi 20 septembre 2014
What do you do?
In an effort to gain more information I was wondering what job do/did you have while at the company? I discovered this forum after I got hired about 2 weeks ago and I'm realizing that this could turn out being a major shit show reading about the layoffs termination and pay. :(
What do you do?
2015 Restructure: How is this going to go down?
A lot of buzz lately about the upcoming sales force realignment.
2015 Restructure: How is this going to go down?
JAMEIS IS OUT FOR THE GAME!!!
Jimbo Fisher (FSU Head Coach) is a man of very high moral integrity. I cannot believe that it took so much public outrage that he finally benched Jameis for the entire game. Any other Head Coach of any other Major Program would have benched Jamies for a few games!
I am really hoping that Clemson wins tonight and FSU is totally out of the running the National Championship and Jameis is not even given any consideration for the Heisman.
What FSU needs to realize is that now there is a Playoff Selection Committee and I sincerely believe that the Committee will take this issue into consideration when selecting the 4 teams.
I am really hoping that Clemson wins tonight and FSU is totally out of the running the National Championship and Jameis is not even given any consideration for the Heisman.
What FSU needs to realize is that now there is a Playoff Selection Committee and I sincerely believe that the Committee will take this issue into consideration when selecting the 4 teams.
JAMEIS IS OUT FOR THE GAME!!!
Today's average base salary?
What is the average base salary today of a Takeda/Quintiles rep?
I am thinking it is around 65-70k base, but I have no idea…
Just know what I make, and was curious what the ballpark was of other reps…
I am thinking it is around 65-70k base, but I have no idea…
Just know what I make, and was curious what the ballpark was of other reps…
Today's average base salary?
Put a Fork in US
ImClone is done. Name retired. Fully integrated into Lilly. The ImClone culture of old completely swept away. Time to move this forum to Lost Civilizations. Very unfortunate but inevitable.
Put a Fork in US
We can put a little emotion behind it now.
I will put a lot of emotion. Passion too....to get the hell out of here! We're so far off projections that in 2016, 100 million in sales will be reached!
We can put a little emotion behind it now.
Open Michigan position
I am thinking about interviewing for a position in Detroit area, anyone know the managers here and if this would be a good area?
Open Michigan position
Managed markets "kam NYC"
What's the deal with the managed markets guy busted down to a territory rep spot on Long Island?
Managed markets "kam NYC"
vendredi 19 septembre 2014
Managed Market KAMS ?
I heard that Managed Care KAMs will be fine since Cosentyx and LCZ are coming. Anyone have ACCURATE information ?
Managed Market KAMS ?
Shame on you...GSK leaders
I retired from GSK because I hated my job. Since that day I have realized that work can be enjoyable if it is meaningful. At GSK it was a useless waste of time that payed a paycheck.
What are GSK leaders doing to change this? Taking big payouts and let GSK fail.
The stock holders must be a bunch of fools also. All the pipeline products are failures.
What are GSK leaders doing to change this? Taking big payouts and let GSK fail.
The stock holders must be a bunch of fools also. All the pipeline products are failures.
Shame on you...GSK leaders
Dear Pfizer
Dear Pfizer,
Please, please, pretty please, with sugar on top, buy Actavis. I need to cash out my equity so I can move on from this clown show. Will be checking the news every ten minutes between now and Monday AM.
Thank you
Please, please, pretty please, with sugar on top, buy Actavis. I need to cash out my equity so I can move on from this clown show. Will be checking the news every ten minutes between now and Monday AM.
Thank you
Dear Pfizer
Another Week National TRX's dipped.
Let the micromanaging, emails, bs begin! Disruption!
Another Week National TRX's dipped.
Project Manager, Medcomms US-Pennsylvania-Philadelphia
Functioning as a key member of an account team, the Project Manager is responsible for the coordination of all account activities, including seeing projects through from confirmation to completion and delivery to the client. Specific responsibilities include:1. Coordinate the management of high quality medical communication projects• Works closely with the Client Service Manager (CSM) to ensure timely completion of all tactics according to budget• Review and understand project specifications as defined in contracts, proposals, and letters of agreement• Alert CSM to requests for services beyond those specified by the original contract• Responsible for regularly reporting project status and progress to the CSM, requesting invoices and maintaining complete project files• Ensure that the approved systems and procedures are closely followed to ensure ‘best practice’ delivery of all projects• Schedule and participate in project start-up and status meetings, including preparation of agenda and status, and recording of all action items• Prepare and maintain timelines upon initiation of projects• Traffic projects from initiation through completion within department and externally• Manage administrative and related activities of assigned Strategic Communication Programs, i.e. databases, references, journals, meetings• In consultation with the medical writer, utilize the EndNotes database for styling and submission of manuscripts• Take remedial action, in consultation with the CSM, when potential problems are identified2. Financial • Monitor project costs in close liaison with the Finance Department • Prepare quotes, as requested, within an agreed timeframe• Responsible for reporting project associated time on a daily basis3. Regular liaison with internal and external teams and clients, authors and suppliers to aid successful delivery of projects• Be the central source of information for the projects within the account and provide account team members with all relevant and necessary information at every stage of the project’s life• Maintain close contact with the client and any external contributors, speakers, meeting support agencies, as appropriate• Share knowledge and expertise with colleagues to assist in the overall growth of the company4. Any other duties, as may be required by the Account Team
More...
More...
Project Manager, Medcomms US-Pennsylvania-Philadelphia
Client Services Manager US-Pennsylvania-Philadelphia
Job duties1. Managing projects on-time and on-budget according to SOPs and client standards:a. Oversee development of the project brief with the client, work with other members of the delivery team to deliver projects (publications, meetings, multimedia, thought leader development, customized products to name a few) in accordance with the needs of the client and target audience.b. Work as part of the delivery team and provide input to all project discussions adding value with creative ideas, concepts or suggestions.c. Develop and implement budgets and milestones with client teams on all projects.d. Communicate project status and milestone achievement with delivery team and SH colleagues.e. Alert colleagues to any potential problems in a timely manner.f. Be aware of specific SH style guidelines and working procedures and adhere to SH project processes.g. Utilize client facing skills to update client on projects and discuss and agree to changes to the project specification where necessary.h. Act as the primary point of contact for current clients and clinical experts during the implementation of a project.i. Be part of the on-site team for scientific meetings; the client service manager’s role may include; i. leading and managing the on-site team ii. ensuring all logistical aspects of the slide previews iii. carrying out the front-of-house role during the symposium iv. ensuring faculty are briefed regarding timing and the meeting format v. liaising with the PowerPoint/AV Manager, Medical Writer, where appropriate vi. distributing the abstract book and any other materialsj. Attend and manage client meetings as part of the delivery team, as required.k. Attend and manage internal status meetings with team, including updating all meeting minutes and meeting reports.l. Ensure projects are managed or delegated and delivered despite conflicting schedules and increased workloads. 2. Build and sustain long-term influential business relationships with client team(s):a. Develop and maintain awareness and understanding of the client’s market, product profile, competitors and trends.b. Keep an overview of issues arising with clients within account team(s) and work with Client Services Director, Account Director to ensure they are resolved so that future relationships are not damaged. 3. Effectively oversee all financial aspects of SH accounts:a. Development of full budget proposals based on client brief including liaison with delivery team regarding hours and costs.b. Effectively manage account finances including ensuring new project codes are raised, invoices are raised at the appropriate times, financial tracking is carried out, including highlighting any changes in budget or specification are raised (and agreed) with the clients, through to final reconciliations.c. Effectively manage and keep up to date the internal financial tracking tools (ie, Central Time) with all financial information. 4. Provide estimates revenue forecasting for SH:a. On a monthly basis, provide a revenue report and forecast for current accounts .b. Assist the financial team by advising on the phased revenue uptake of Medical Communication activities. 5. Work with the Sales Team to provide commercially driven input into business development activities:a. Contribute to new business proposals/RFPs and pitches including slide development and attending pitches. 6. Cross company support:a. Provide support for delivery to other Springer companies where required.b. Liaise with other Springer companies to promote SH products and services, participating in joint pitches where required. 7. Domestic and some international travel required 8. Any other duties as required by your manager
More...
More...
Client Services Manager US-Pennsylvania-Philadelphia
Innovative Diagnostic Lab
Anyone know anything about this lab? This company is based in Richmond VA and uses Cobalt Healthcare Consultants to market their labs. Wondering if the company is a subsidiary of Health Diagnostics Labs....same base city, same consultants selling the test (HDL uses Bluewave, IDL uses Cobalt, both consulting companies are owned by the same people).
Innovative Diagnostic Lab
KCI Management
AVPs mad DMs
We know you visit this site. Please read and take notice of what's going on. These posts can't be written off as a few disgruntled bad apples. Go to Hawkins and plead for him to turn this thing around. Look at the facts and if you can't see it, bring consultants in. A few pockets of sales of focus products are the exception and not the norm. Why doesn't a company this size have better products? IT'S NOT THE SALES FORCE!!! Over 200 resumes have with key words like "wound" and "NPWT" have hit the internet in the last 3 weeks. You are facing a crisis. do something
We know you visit this site. Please read and take notice of what's going on. These posts can't be written off as a few disgruntled bad apples. Go to Hawkins and plead for him to turn this thing around. Look at the facts and if you can't see it, bring consultants in. A few pockets of sales of focus products are the exception and not the norm. Why doesn't a company this size have better products? IT'S NOT THE SALES FORCE!!! Over 200 resumes have with key words like "wound" and "NPWT" have hit the internet in the last 3 weeks. You are facing a crisis. do something
KCI Management
Bounty
Since Amgen is shit-canning their research, I hereby place a bounty of $1000 on the head of that George Rathmann sculpture. Either one, or both. It must be done Jebediah Springfield style.
Alternatively, you can remove the Pauling Dr. street sign and mount it in SK's office. The choice is yours.
I can pay via Paypal, we can do a kickstarter, or you can post it on Ebay or Craigslist- your choice.
Alternatively, you can remove the Pauling Dr. street sign and mount it in SK's office. The choice is yours.
I can pay via Paypal, we can do a kickstarter, or you can post it on Ebay or Craigslist- your choice.
Bounty
No calibration for Acute Care - Only Tablet??
Does this mean Hospital Layoffs predicted for this October are only for the Tablet Reps? We are being calibrated first part of the month. Does anyone have any truthful info? Please, no wisecracks.
No calibration for Acute Care - Only Tablet??
GSK's Letter Of Apology To Chinese
GSK's Letter Of Apology To Chinese
Updated: 9:41am UK, Friday 19 September 2014
GSK's statement of apology to the people of China:
Following a comprehensive investigation by the Chinese judicial authorities, GSK China Investment Co Ltd (GSKCI) has been identified according to Chinese law to have offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel.
GSK plc fully accepts the facts and evidence of the investigation, and the verdict of the Chinese judicial authorities.
Furthermore, GSK plc sincerely apologises to the Chinese patients, doctors and hospitals, and to the Chinese Government and the Chinese people.
GSK plc deeply regrets the damage caused.
GSK plc also apologises for the harm caused to individuals who were illegally investigated by GSKCI.
The illegal activities of GSKCI are a clear breach of GSK plc’s governance and compliance procedures; and are wholly contrary to the values and standards we expect from our employees.
It is deeply disappointing that these issues were not identified and addressed.
GSK plc has reflected deeply and learned from its mistakes, has taken steps to comprehensively rectify the issues identified at the operations of GSKCI, and must work hard to regain the trust of the Chinese people.
Today, GSK plc makes a further commitment to the Chinese government and people that GSKCI will take tangible actions to establish itself as a model for reform in China’s healthcare industry: by continuing to invest in China and supporting China's scientific development; and by further development of innovative new medicines and vaccines for diseases prevalent in China.
GSKCI will also increase access to its products in both city and rural areas of China through greater expansion of production and through price flexibility.
This long-term development strategy of GSK plc will promote the future health and well-being of the Chinese people, and positively contribute to China’s economic and social development.
Updated: 9:41am UK, Friday 19 September 2014
GSK's statement of apology to the people of China:
Following a comprehensive investigation by the Chinese judicial authorities, GSK China Investment Co Ltd (GSKCI) has been identified according to Chinese law to have offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel.
GSK plc fully accepts the facts and evidence of the investigation, and the verdict of the Chinese judicial authorities.
Furthermore, GSK plc sincerely apologises to the Chinese patients, doctors and hospitals, and to the Chinese Government and the Chinese people.
GSK plc deeply regrets the damage caused.
GSK plc also apologises for the harm caused to individuals who were illegally investigated by GSKCI.
The illegal activities of GSKCI are a clear breach of GSK plc’s governance and compliance procedures; and are wholly contrary to the values and standards we expect from our employees.
It is deeply disappointing that these issues were not identified and addressed.
GSK plc has reflected deeply and learned from its mistakes, has taken steps to comprehensively rectify the issues identified at the operations of GSKCI, and must work hard to regain the trust of the Chinese people.
Today, GSK plc makes a further commitment to the Chinese government and people that GSKCI will take tangible actions to establish itself as a model for reform in China’s healthcare industry: by continuing to invest in China and supporting China's scientific development; and by further development of innovative new medicines and vaccines for diseases prevalent in China.
GSKCI will also increase access to its products in both city and rural areas of China through greater expansion of production and through price flexibility.
This long-term development strategy of GSK plc will promote the future health and well-being of the Chinese people, and positively contribute to China’s economic and social development.
GSK's Letter Of Apology To Chinese
No calibration for Acute Care - Only Tablet??
Does this mean Hospital Layoffs predicted for this October are only for the Tablet Reps? We are being calibrated first part of the month. Does anyone have any truthful info? Please, no wisecracks.
No calibration for Acute Care - Only Tablet??
GSK's Letter Of Apology To Chinese
GSK's Letter Of Apology To Chinese
Updated: 9:41am UK, Friday 19 September 2014
GSK's statement of apology to the people of China:
Following a comprehensive investigation by the Chinese judicial authorities, GSK China Investment Co Ltd (GSKCI) has been identified according to Chinese law to have offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel.
GSK plc fully accepts the facts and evidence of the investigation, and the verdict of the Chinese judicial authorities.
Furthermore, GSK plc sincerely apologises to the Chinese patients, doctors and hospitals, and to the Chinese Government and the Chinese people.
GSK plc deeply regrets the damage caused.
GSK plc also apologises for the harm caused to individuals who were illegally investigated by GSKCI.
The illegal activities of GSKCI are a clear breach of GSK plc’s governance and compliance procedures; and are wholly contrary to the values and standards we expect from our employees.
It is deeply disappointing that these issues were not identified and addressed.
GSK plc has reflected deeply and learned from its mistakes, has taken steps to comprehensively rectify the issues identified at the operations of GSKCI, and must work hard to regain the trust of the Chinese people.
Today, GSK plc makes a further commitment to the Chinese government and people that GSKCI will take tangible actions to establish itself as a model for reform in China’s healthcare industry: by continuing to invest in China and supporting China's scientific development; and by further development of innovative new medicines and vaccines for diseases prevalent in China.
GSKCI will also increase access to its products in both city and rural areas of China through greater expansion of production and through price flexibility.
This long-term development strategy of GSK plc will promote the future health and well-being of the Chinese people, and positively contribute to China’s economic and social development.
Updated: 9:41am UK, Friday 19 September 2014
GSK's statement of apology to the people of China:
Following a comprehensive investigation by the Chinese judicial authorities, GSK China Investment Co Ltd (GSKCI) has been identified according to Chinese law to have offered money or property to non-government personnel in order to obtain improper commercial gains, and has been found guilty of bribing non-government personnel.
GSK plc fully accepts the facts and evidence of the investigation, and the verdict of the Chinese judicial authorities.
Furthermore, GSK plc sincerely apologises to the Chinese patients, doctors and hospitals, and to the Chinese Government and the Chinese people.
GSK plc deeply regrets the damage caused.
GSK plc also apologises for the harm caused to individuals who were illegally investigated by GSKCI.
The illegal activities of GSKCI are a clear breach of GSK plc’s governance and compliance procedures; and are wholly contrary to the values and standards we expect from our employees.
It is deeply disappointing that these issues were not identified and addressed.
GSK plc has reflected deeply and learned from its mistakes, has taken steps to comprehensively rectify the issues identified at the operations of GSKCI, and must work hard to regain the trust of the Chinese people.
Today, GSK plc makes a further commitment to the Chinese government and people that GSKCI will take tangible actions to establish itself as a model for reform in China’s healthcare industry: by continuing to invest in China and supporting China's scientific development; and by further development of innovative new medicines and vaccines for diseases prevalent in China.
GSKCI will also increase access to its products in both city and rural areas of China through greater expansion of production and through price flexibility.
This long-term development strategy of GSK plc will promote the future health and well-being of the Chinese people, and positively contribute to China’s economic and social development.
GSK's Letter Of Apology To Chinese
Bounty
Since Amgen is shit-canning their research, I hereby place a bounty of $1000 on the head of that George Rathmann sculpture. Either one, or both. It must be done Jebediah Springfield style.
Alternatively, you can remove the Pauling Dr. street sign and mount it in SK's office. The choice is yours.
I can pay via Paypal, we can do a kickstarter, or you can post it on Ebay or Craigslist- your choice.
Alternatively, you can remove the Pauling Dr. street sign and mount it in SK's office. The choice is yours.
I can pay via Paypal, we can do a kickstarter, or you can post it on Ebay or Craigslist- your choice.
Bounty
jeudi 18 septembre 2014
Does SLS matter any more?
My manager wants me to apply for SLS during year end PC, but I'm not sure I see value in this. Does the company even care or respect the SLS members anymore? Back in the day when it was an award for career achievement it was a great thing (called Legion of Excellence), but not it's another way to humiliate us with behaviors and performance. Should I bother? Honest responses please
Does SLS matter any more?
Drop in Januvia sales
Put on a competitor drug and bloodwork came out BETTER! And I don't have to worry about cancer! How about that. :-)
Drop in Januvia sales
Trulicity-Lilly's QW is approved
Once weekly, smaller needle, no nodules and look at where it is indicated.
"The FDA said that the safety and efficacy of Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, had been studied in 3,342 type 2 diabetics. The drug can be given as monotherapy or in combination with other diabetes drugs including metformin, sulfonylurea, thiazolidinediones, and prandial insulin"
Can be used with PRANDIAL INSULIN because it is known that QW GLP1's have more effect on fasting than PPG. Which is why BYD has no indication with basal and simply does not work for PPG. Lilly's indications for Trulicity will reinforce to physicians the limitations of BYD and how they have be misled to believe it is interchangeable with Byetta and Victoza.
"The FDA said that the safety and efficacy of Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, had been studied in 3,342 type 2 diabetics. The drug can be given as monotherapy or in combination with other diabetes drugs including metformin, sulfonylurea, thiazolidinediones, and prandial insulin"
Can be used with PRANDIAL INSULIN because it is known that QW GLP1's have more effect on fasting than PPG. Which is why BYD has no indication with basal and simply does not work for PPG. Lilly's indications for Trulicity will reinforce to physicians the limitations of BYD and how they have be misled to believe it is interchangeable with Byetta and Victoza.
Trulicity-Lilly's QW is approved
Martin Clark, where R you now ?
Any ideas as to where this nut job is today? Crazy but job " West Point" disgrace!!!
Martin Clark, where R you now ?
Managed Markets, bye TK
Hello to who? Perhaps Newass-man but we'll have to wait and see. I must say I am on pins and needles here. It's kinda itchy.
Managed Markets, bye TK
Primary Care Opportunities
What's base range and target bonus? Are reps hitting bonus generally and how does JnJ determine base increase ie #of years in pharma or current base?
Products? Package etc.. Thanks
Products? Package etc.. Thanks
Primary Care Opportunities
Why is PBG pushing these mediocre products down our throat?
I thought we were all in this business to sell implants and grow surgical practices. So why are they pushing a seldom used mini (LOADI) implant to GPs who are too cheap to buy a torque wrench and a $100 box of spungs? Just okay to have in the catalog but far from a money maker or even practice builder. Management is suspect
Why is PBG pushing these mediocre products down our throat?
EVA....the dumbest pharmaceutical innovation ever,
Disruption! Dr., come see my new picture book! Duck, duck, goose!
EVA....the dumbest pharmaceutical innovation ever,
Big Takeaway From Meeting. 60 million spent 14 million made!
DM's and ROTA's to be cut next week.
Big Takeaway From Meeting. 60 million spent 14 million made!
Another dead end situation...
Worst decision to move into a contract organization. don't do it people. Trust me!
and the Field Goal is good!
LOL.
and the Field Goal is good!
LOL.
Another dead end situation...
Executive Medical Practice Sales Consultant US
MedTech Healthcare Solutions is an independent licensee of the #1 nationwide network, with over 1500 offices nationwide, specializing in revenue cycle solutions, medical practice management, and private practice business support throughout the U.S.We are currently seeking Executive Sales Consultants to join our team. This position is a full of part time opportunity and is a commission based position. The Consultant will be in charge of developing new business relationships through direct contact with private medical practices, managing leads, and following up with potential clients in order to schedule practice analyses.This a fantastic opportunity for Sales Reps that have pre-existing relationships and contacts in the medical industry. The ideal candidate will bring a book of pre-existing contacts that can utilized to develop new business relationships with MedTech Healthcare Solutions.We will provide you with all the tools and training that you need to be successful!$1500 Commission per each signed on account.Requirements:- Minimum of 1 year of successful outside sales experience - Previous work/sales history in and/or around the medical industry - Trusted to work independently and positively represent our Company- Self starter, self motivated, and initiative driven individual - Positive, can do personality!Preferred: - Minimum of 1 year of medical sales related experience - Existing relationships and contacts in the medical industry- Willingness to leverage and utilize existing medical industry relationships and contacts to develop new business opportunities
More...
More...
Executive Medical Practice Sales Consultant US
mercredi 17 septembre 2014
1099 Dental regenerative materials+ US
We pay 10-20% commission on our products. The widest selection of regenerative materials of any dental company available for saleOpportunity to sell ancillary products as well like instrumentation, cements, education etc.Looking for people already in the field or people looking to educate themselves for future positions.
More...
More...
1099 Dental regenerative materials+ US
Aerospan
Are people hitting the Aerospan number for Q3? If so, What are you all doing? I am lucky to get one script a week. Never have I had such a difficult time selling a med. I feel that the tools came to us late and managed care has been difficult with this product. I feel it is a upward climb but very slow.
Aerospan
Field sales/ Salary and earning potential
Was interested in getting into this industry. Was do the field sales reps make in base? was is a realistic commission check here monthly. How does one make commissions here with the DME? How does this company compare to other competitors like PPS etc...??
Field sales/ Salary and earning potential
PSS vs competitors
How does PPS stack up to the competitors? Got a call from a recruiter and was wondering what is the real world sell on these products vs competitors. Are the PPS products are Medicare? How do you make money here? Why would an office choose PPS vs L-care.
Please any insight would help...
Please any insight would help...
PSS vs competitors
Tokai
Tokai pockets $97M in IPO cash to get its cancer drug into Phase III
This biotech has a three-in-one prostate cancer treatment that's been fast tracked by the FDA.
This biotech has a three-in-one prostate cancer treatment that's been fast tracked by the FDA.
Tokai
Genzyme is making there move for all OI reps
Genzyme is paying well to try and take all the good reps... We will see.. Anything looks positive outside of here..
Genzyme is making there move for all OI reps
CLUSTER 1
What products does Cluster 1 promote? Viagra & Celebrex? You think a rural area for PHR is safe or what? Good Luck!
CLUSTER 1
Question asked on today's call
To the Primera Rep "promoted" to Innovia:
Adrian is not going to accelerate your training program just so you don't get fired when Endo takes over.
That question was embarrassing - please go punch yourself in the face.
Adrian is not going to accelerate your training program just so you don't get fired when Endo takes over.
That question was embarrassing - please go punch yourself in the face.
Question asked on today's call
Milton Packer congrats !
NVS clinical studies must pay handsomely !
98. Beth Levine and Milton Packer
$5,000,000
They are one of Dallas’ premier white-lab-coat-wearing power couples. Both are on the faculty at UT Southwestern, where Beth, 49, holds the Jay P. Sanford Professorship in Infectious Diseases, and Milton, 53, heads up the Center for Biostatistics and Clinical Science. Both have done extensive research on heart failure, and your heart just might stop if you’re ever invited to their 10,088-square-foot manor, which was built in 1934. The couple purchased the mansion in January 2004 from Randall and Cynthia Murphy (Randall founded the consulting firm Acclivus in 1976), and that put them on the list even though the value of the house itself was adjusted downward, from $3 million to $1.7 million. Still, after a hard day discussing ventricles, they can kick back and enjoy their six fireplaces, six baths (and three half baths!), and a wet bar. But only for medicinal purposes, we assume.
http://ift.tt/1tfMibx
98. Beth Levine and Milton Packer
$5,000,000
They are one of Dallas’ premier white-lab-coat-wearing power couples. Both are on the faculty at UT Southwestern, where Beth, 49, holds the Jay P. Sanford Professorship in Infectious Diseases, and Milton, 53, heads up the Center for Biostatistics and Clinical Science. Both have done extensive research on heart failure, and your heart just might stop if you’re ever invited to their 10,088-square-foot manor, which was built in 1934. The couple purchased the mansion in January 2004 from Randall and Cynthia Murphy (Randall founded the consulting firm Acclivus in 1976), and that put them on the list even though the value of the house itself was adjusted downward, from $3 million to $1.7 million. Still, after a hard day discussing ventricles, they can kick back and enjoy their six fireplaces, six baths (and three half baths!), and a wet bar. But only for medicinal purposes, we assume.
http://ift.tt/1tfMibx
Milton Packer congrats !
Stock buybacks not always a good idea
“The first half of 2014 has been the best start to the year ($338billion) since 2007 ($361 billion), the current record year for buyback authorizations and executions,” writes Birinyi analyst Rob Leiphart. “And since the bear market ended on March 9, 2009, the current quarter ($157 billion) is the third best (out of 22 quarters) during the current bull market.”
This matters because with fewer shares circulating after a buyback, earnings per share – a key metric in valuing stocks – are boosted even if net income declines. According to a recent study by Barclays, share buybacks are now responsible for about 2 percent of total earnings for the S&P 500. What’s more, companies that have the highest share repurchases have outperformed the rest of the market since mid-2008.
Gina Sanchez, founder of Chantico Global, pins share buybacks squarely on the shoulders of the Federal Reserve’s quantitative easing program. She sees the S&P 500’s recent record highs as a byproduct of buybacks, not high levels of revenues.
“It is shocking that this continues,” said Sanchez about buybacks. “What we have seen is continued evidence that all of this monetary expansion has found its way into earnings – [into] everything except for real demand and sales.”
Labeling earnings over the past five or six years as “just OK,” Sanchez said net income has only recently started to pick up. However, she believes investors have been buying into momentum over the past few years.
This matters because with fewer shares circulating after a buyback, earnings per share – a key metric in valuing stocks – are boosted even if net income declines. According to a recent study by Barclays, share buybacks are now responsible for about 2 percent of total earnings for the S&P 500. What’s more, companies that have the highest share repurchases have outperformed the rest of the market since mid-2008.
Gina Sanchez, founder of Chantico Global, pins share buybacks squarely on the shoulders of the Federal Reserve’s quantitative easing program. She sees the S&P 500’s recent record highs as a byproduct of buybacks, not high levels of revenues.
“It is shocking that this continues,” said Sanchez about buybacks. “What we have seen is continued evidence that all of this monetary expansion has found its way into earnings – [into] everything except for real demand and sales.”
Labeling earnings over the past five or six years as “just OK,” Sanchez said net income has only recently started to pick up. However, she believes investors have been buying into momentum over the past few years.
Stock buybacks not always a good idea
Inscription à :
Articles (Atom)